• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,702.98 -735.30
(-1.55%)
Dow Jones
6,694.68 -102.12
(-1.50%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,300.41 -53.36
(-0.52%)
Forex
USD-INR
91.92 0.02
(0.02%)
EUR-INR
106.58 -0.28
(-0.27%)
GBP-INR
123.39 -0.12
(-0.10%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.5573934
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
23.72
110068.55
EPS(TTM)
Face Value()
Div & Yield %
55.59
1
0.61
 

Welspun Corp approves acquisition of further 4.11% stake in Welspun Specialty Solutions
Oct 30,2025
The board of Welspun Corp at its meeting held on 30 October 2025 has approved the acquisition of 2,72,39,744 equity shares (4.11% equity stake) of Welspun Specialty Solutions, subsidiary company, from the Promoter Group at the market price subject to compliance of applicable laws.

Upon completion of this acquisition, the Company's equity holding in Welspun Specialty Solutions will increase from 51.06% to 55.17%.